Health
Research into COVID treatments catching up – Esperance Express
Australia has closed a deal for 300,000 courses of an antiviral pill showing promising signs of slashing COVID-19 deaths and…
Australia has closed a deal for 300,000 courses of an antiviral pill showing promising signs of slashing COVID-19 deaths and hospitalisations.
Molnupiravir is still being trialled in the US and is yet to gain regulatory authorisation.
But the federal government…
Continue Reading
-
Noosa News13 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General14 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
General11 hours agoIncreased police powers begin at Adelaide Oval Ashes Test following Bondi attacks
-
Noosa News15 hours agoThe Best Things to Do in Brisbane This New Year’s Eve